Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates

Chimeric antigen receptor (CAR) T cells targeting CD19(+) hematologic malignancies have rapidly emerged as a promising, novel therapy. In contrast, results from the few CAR T-cell studies for infectious diseases such as HIV-1 have been less convincing. These challenges are likely due to the low leve...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Rust, Blake J., Kean, Leslie S., Colonna, Lucrezia, Brandenstein, Katherine E., Poole, Nikhita H., Obenza, Willimark, Enstrom, Mark R., Maldini, Colby R., Ellis, Gavin I., Fennessey, Christine M., Huang, Meei-Li, Keele, Brandon F., Jerome, Keith R., Riley, James L., Kiem, Hans-Peter, Peterson, Christopher W.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Gene Therapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7544543/
https://ncbi.nlm.nih.gov/pubmed/32614969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020006372
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars